Success Metrics

Clinical Success Rate
97.9%

Based on 46 completed trials

Completion Rate
98%(46/47)
Active Trials
8(12%)
Results Posted
22%(10 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_1
1
2%
Ph phase_3
3
5%
Ph phase_4
4
6%
Ph not_applicable
46
70%
Ph phase_2
5
8%

Phase Distribution

1

Early Stage

5

Mid Stage

7

Late Stage

Phase Distribution59 total trials
Phase 1Safety & dosage
1(1.7%)
Phase 2Efficacy & side effects
5(8.5%)
Phase 3Large-scale testing
3(5.1%)
Phase 4Post-market surveillance
4(6.8%)
N/ANon-phased studies
46(78.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.8%

46 of 48 finished

Non-Completion Rate

4.2%

2 ended early

Currently Active

8

trials recruiting

Total Trials

66

all time

Status Distribution
Active(9)
Completed(46)
Terminated(2)
Other(9)

Detailed Status

Completed46
unknown9
Recruiting4
Active, not recruiting4
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
66
Active
8
Success Rate
97.9%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (1.7%)
Phase 25 (8.5%)
Phase 33 (5.1%)
Phase 44 (6.8%)
N/A46 (78.0%)

Trials by Status

completed4670%
withdrawn12%
unknown914%
recruiting46%
not_yet_recruiting12%
terminated12%
active_not_recruiting46%

Recent Activity

Clinical Trials (66)

Showing 20 of 66 trialsScroll for more
NCT00687115Phase 2

Predicting Weight Gain and Weight Loss Associated With Overeating or Fasting

Completed
NCT04228978Not Applicable

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

Recruiting
NCT05707442Phase 3

Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)

Recruiting
NCT06399276Not Applicable

4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity

Active Not Recruiting
NCT07223242Phase 2

Tailored Exercise Training Study Among Adults With HFpEF

Recruiting
NCT01104220Not Applicable

Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk

Active Not Recruiting
NCT07174817Not Applicable

Weight Loss on IVF Outcomes in Overweight and Obese Infertile Women

Completed
NCT04370093Phase 4

Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss

Completed
NCT05937074

Metabolic Response to Food in Lung Cancer

Active Not Recruiting
NCT05748158Not Applicable

A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program

Recruiting
NCT07023133

Impact of Weight Loss on Mitochondrial Function

Not Yet Recruiting
NCT04841915Not Applicable

Dairy Protien Rich Diet for NAFLD Patients

Completed
NCT03271034Not Applicable

Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema

Completed
NCT02994459

Study of Fat Tissue's Ability to Take up Sugar in the Obese Population

Active Not Recruiting
NCT00285844Phase 1

Integrating the Genetic and Metabolic Faces of Obesity

Completed
NCT02607033Not Applicable

Exercise and Weight Loss in PAD

Completed
NCT04730557Not Applicable

Reducing Obesity and Cartilage Compression in Knees

Completed
NCT04825483Not Applicable

Effects of a Weight Loss Program in People With Hip Osteoarthritis

Completed
NCT02399423Not Applicable

The GlasVEGAS Study (Glasgow Visceral & Ectopic Fat With Weight Gain in South AsianS)

Completed
NCT03771261Not Applicable

Balanced (Egg) Protein During Obesity Reduction: Differential Responses of Insulin Resistance by Race

Completed

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
66